Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yoshinori, Furuhata"'
Autor:
Satoshi Ikeuchi, Yoshikazu Kinoshita, Hideaki Miyagishi, Yoshinori Furuhata, Motoyasu Kusano, Michio Hongo
Publikováno v:
Internal Medicine
Objective To investigate the effect of twice-daily rabeprazole doses on health-related quality of life in refractory patients. Methods and Patients Reflux esophagitis patients with an insufficient response to once-daily proton pump inhibitor therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a436d745c7c02e5a7d1f339973fcd7
https://pubmed.ncbi.nlm.nih.gov/28502925
https://pubmed.ncbi.nlm.nih.gov/28502925
Autor:
Norio Iinuma, Yukinori Sakata, Yoshinori Furuhata, Hitoshi Suzuki, Katsuya Sugizaki, Toshihisa Arai
Publikováno v:
Internal Medicine. 51:3103-3108
Objective Triple therapy with rabeprazole (RPZ), amoxicillin (AMPC) and metronidazole (MNZ) (RPZ+AMPC+MNZ therapy: RAM therapy) has been approved by the Japanese Ministry of Health, Labour and Welfare as a second-line therapy for Helicobacter pylori-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1f1009e2c084fc74eb13b05a2fecf8c
https://doi.org/10.2169/internalmedicine.51.8510
https://doi.org/10.2169/internalmedicine.51.8510
Publikováno v:
ACTA HISTOCHEMICA ET CYTOCHEMICA. 31:329-334
Egg white lysozyme is now used clinically for the therapy of inflammatory diseases of respiratory tracts by oral administration. No definite evidence, however, has been presented to show directly the intestinal absorption of lysozyme molecules keepin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::878eaf4abbaa44f8735a42d4fe91e8e8
https://doi.org/10.1267/ahc.31.329
https://doi.org/10.1267/ahc.31.329
Autor:
Katsuya, Sugizaki, Yukinori, Sakata, Toshihisa, Arai, Yoshinori, Furuhata, Norio, Iinuma, Hitoshi, Suzuki
Publikováno v:
Internal medicine (Tokyo, Japan). 51(22)
Triple therapy with rabeprazole (RPZ), amoxicillin (AMPC) and metronidazole (MNZ) (RPZ+AMPC+MNZ therapy: RAM therapy) has been approved by the Japanese Ministry of Health, Labour and Welfare as a second-line therapy for Helicobacter pylori-positive g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::51d513472dcc1760993a881c0e1e6ca7
https://pubmed.ncbi.nlm.nih.gov/23154713
https://pubmed.ncbi.nlm.nih.gov/23154713
Publikováno v:
5th International Conference on Spoken Language Processing (ICSLP 1998).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::589883f51d3831384555b338d88fd333
https://doi.org/10.21437/icslp.1998-536
https://doi.org/10.21437/icslp.1998-536